Increased Growth Factor Production with BPC-157 Research indicates that BPC 157 can increase growth factors in tendon fibroblasts, which in turn may lead to an increase in muscle fibers
While they may offer benefits, they come with more significant considerations: Source quality matters: Not all compounding pharmacies follow strict standards No established protocols: Dosing varies widely Limited human safety data: Most research is preclinical Potential for side effects: Including injection site reactions, immune responses, and unknown long-term effects Regulatory status: Most are not FDA-approved for any medical indication Safety Considerations and Final Thoughts Peptides are an exciting area of research, and we are optimistic about their potential role in plastic surgery recovery
Telehealth or In-Person Follow-Up Follow-up care may be completed online or in person, depending on patient needs and availability
doi:10.1016/S0076-6879(85)13053-3
[1] The Human Evidence Gap and Where Research Is Heading The most intellectually honest statement about BPC-157 is this: an unusually robust preclinical literature has established a plausible and broadly consistent mechanistic picture, while the human clinical trial evidence remains essentially absent
You can also choose to live in a transition house if you prefer, but it is not a requirement